About PeptideClear

PeptideClear is independent UK editorial coverage of GLP-1 weight-loss medication, research peptides, cosmetic peptides and collagen, written and reviewed by the PeptideClear editorial team with no medical advisory board. It does not prescribe, dispense or recommend specific medications: we cite sources for our claims (MHRA PILs, NICE guidance, peer-reviewed research) and are adding them where missing, rather than relying on clinical credentials, rankings are refreshed quarterly with immediate re-review on material changes, and the site is operated by Best Business Loans Ltd (company number 16833937).

PeptideClear is independent UK peptide intelligence. We grade evidence. We do not prescribe. Four product categories sit on this site: cosmetic peptide skincare, ingestible collagen, research peptides, and prescription GLP-1 weight-loss medication. We are not a pharmacy, not a clinic, not a research peptide retailer. Every CTA leads off-site to a verified UK partner. Every page is editorial commentary.

How we are credibly different

We do not have a medical advisory board. We rely on published research. This is the deliberate credibility frame for a site that is editorial, not clinical. The model is Examine.com, the independent supplement-research database that built one of the strongest reputations in evidence-based nutrition without a single named clinician on staff. Examine grades evidence. Examine does not give medical advice. That is the same posture PeptideClear takes for UK peptides.

The reasoning is straightforward. For a Your Money Your Life (YMYL) topic like peptide products, two credibility paths exist. The first is credentialled-reviewer posture: a named medical advisory board, GMC-registered authors, clinical editors. That posture works for sites that publish individual clinical advice. The second is citation-density posture: we cite sources for our claims (PubMed DOI, MHRA notice, NICE technology appraisal, peer-reviewed publication, manufacturer PIL) and are adding them where missing, the source hierarchy is documented, the methodology is published, and the site openly refuses to publish individual clinical advice.

PeptideClear takes the second path. We do not publish dosing protocols. We do not run a symptom-triage runbook. We do not recommend a specific medication to a specific person. Where readers need a clinical decision, the page directs to a UK-registered prescriber. What we do publish is graded, cited, source-tiered editorial comparison of the UK retailer, clinic, and pharmacy landscape, plus encyclopedia-style coverage of the research literature.

The citation density does the YMYL work. Not credentialled names. This is why the source hierarchy at Trust Review is the central editorial document on the site, and why the editorial policy is explicit about which sources lead, which are used with caveat, and which are never used.

Who writes PeptideClear

Written and reviewed by the PeptideClear editorial team. Every page on this site is reviewed against the source hierarchy, the ASA CAP code, MHRA guidance, and Trading Standards advertising standards before publication. PeptideClear is operated by Best Business Loans Ltd, a UK company.

PeptideClear has one editor, so one person is responsible for what we publish and for how we choose sources.

How we work

Four published documents describe the editorial machinery in full:

• · Methodology: per-category criteria for how clinics, pharmacies, retailers, collagen brands, and cosmetic brands are scored, ranked, and included.
• · Editorial policy: the source hierarchy, the sources we lead with, the sources we use with caveat, and the sources we never use.
• · Trust Review: how research-peptide retailers are assessed on the PeptideClear Trust Index, and how clinics and pharmacies are included editorially.
• · Glossary: peptide terminology defined inline, with primary-source citations where the term has a regulated or clinical meaning.

Rankings, comparison tables, and retailer profiles are refreshed quarterly. Material changes (price, policy, regulatory status, Companies House status) trigger immediate re-review outside the quarterly cycle. The full refresh cadence per page family is documented in methodology.

What we cover

• · GLP-1 weight management: Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide). NHS access under NICE TA1026 across the 42 English ICBs. Private routes (high-touch clinics and low-touch pharmacies). Mechanism, cost, switching, aftercare, body composition.
• · Research peptides: BPC-157, TB-500, MOTS-c, Ipamorelin, Sermorelin, Tesamorelin, CJC-1295. Encyclopedia framing only. UK retailer comparison. HPLC purity, CoA standards, regulatory status.
• · Cosmetic peptides: GHK-Cu, Matrixyl 3000, Argireline. UK retailer comparison. INCI position analysis. Stacking with other actives.
• · Collagen: hydrolysed Type I and III (marine, bovine), undenatured Type II (UC-II). UK brands compared on dose, kDa, source transparency, third-party testing.
• · UK longevity clinics: Hooke, Echelon Health, Reliant Healthcare, Human Longevity, Bupa Health Clinics, Nuffield Health. Baseline bloods, imaging, body composition, intervention loops.
• · UK regulators and law: MHRA, GPhC, GMC, NICE, ASA, FSA. Human Medicines Regulations 2012, Misuse of Drugs Act 1971, Psychoactive Substances Act 2016, ASA CAP code.

What we will and will not do

• · We do not prescribe, dispense, or supply prescription medication.
• · We do not recommend specific medications to specific people. Your prescriber decides.
• · We do not publish dosing protocols, missed-dose runbooks, or human-use instructions for research peptides.
• · We do not show before-and-after weight-loss imagery (ASA position).
• · We do not promote compounded GLP-1 or grey-import medication sources.
• · We do not let referral fees decide which clinics, pharmacies, or retailers appear in rankings.
• · We will grade evidence, list source tiers, and cite sources for our claims and add them where missing.
• · We will refresh listings on a fixed quarterly cycle, with immediate re-review on material changes.
• · We will route readers to UK-registered prescribers for every clinical decision.

Operating company

PeptideClear is operated by Best Business Loans Ltd, a UK company registered in England and Wales. Company number 16833937. Registered office: Cust Hall, Toppesfield, Halstead, Essex, CO9 4EB. The same company operates other UK editorial and comparison websites, none of which cover health topics. Those operations are unrelated to PeptideClear's editorial scope.

Contact

Editorial questions, corrections, press enquiries, or partnership requests: hello@peptideclear.co.uk. Corrections are acknowledged within 5 working days.

Related: editorial policy · trust review · methodology · safety and regulation · how we are funded.